In this week’s top news pick from MedTech Strategist Market Pathways: CMS wrestled with the opioid abuse epidemic in its latest round of annual payment rules, but device firms’ efforts to better position spine devices, infusion pumps, and neurostimulators as alternatives to opioids for treating pain were largely unsuccessful.Subscribe now to read the full analysis
Welcome to MyStrategist, an online experience like no other in the medical device industry.
MedTech Strategist's complimentary Community Blog focuses on the people and the passion behind the global device space. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.e-Newsletter Browse
50 confirmed VCs & Investors attending Innovation Summit San Francisco, November 18-19th.Register Learn More Attendee List
'Meet the Innovators' Season 2, Episode 10: A video interview with Andrew Bartynski, co-founder, AesculaTech. Los Angeles-based start-up, AesculaTech, Inc., is developing a platform of temperature-responsive smart materials, including their first product, AesculaGel, a punctal plug for the treatment of dry eye syndrome that is applied as a liquid then solidifies at body temperature and blocks tear ducts.Subscribe now to read the full analysis
Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.Subscribe Free Premier Issue Learn More
Clinical experience in lung and other cancers shows how precision medicine has implications for the medtech world, particularly in the area of tissue biopsies and interventional treatment procedures.Subscribe now to read the full analysis